Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

Increasing evidence shows that metabolic abnormalities in body fluids are distinguishing features of the pathophysiology of Parkinson’s disease. However, a non-invasive approach has not been established in the earliest or pre-symptomatic phases. Here, we report comprehensive double-cohort analyses o...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiki, Shinji, Hatano, Taku, Fujimaki, Motoki, Ishikawa, Kei-Ichi, Mori, Akio, Oji, Yutaka, Okuzumi, Ayami, Fukuhara, Takeshi, Koinuma, Takahiro, Imamichi, Yoko, Nagumo, Miho, Furuya, Norihiko, Nojiri, Shuko, Amo, Taku, Yamashiro, Kazuo, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544708/
https://www.ncbi.nlm.nih.gov/pubmed/28779141
http://dx.doi.org/10.1038/s41598-017-06767-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544708/
https://www.ncbi.nlm.nih.gov/pubmed/28779141
http://dx.doi.org/10.1038/s41598-017-06767-y

Ejemplares similares